Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Molecule to Market: Inside the outsourcing space cover art

Molecule to Market: Inside the outsourcing space

Molecule to Market: Inside the outsourcing space

Written by: Raman Sehgal
Listen for free

About this listen

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.

Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.

https://moleculetomarketpod.com

Copyright 2020 All rights reserved.
Biological Sciences Science
Episodes
  • From Polish Biosimilars to Building a Biologics CDMO
    Nov 13 2026

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development and commercialisation lifecycle with Adriana Kiedzierska, CEO of Rezon Bio.

    Adriana Kiędzierska-Mencfeld is the CEO of Rezon Bio, where she leads the company’s strategy, operations and partnerships across biologics development and manufacturing. With more than 20 years of experience in biotechnology, she specialises in recombinant proteins, purification and biosimilars.

    Previously, she held senior roles at Polpharma Biologics, including COO and Site Head, where she helped support the transition to commercial scale manufacturing and contributed to FDA and EMA approvals. Adriana holds a PhD from the University of Wrocław and an Executive MBA from IMD, combining deep technical expertise with strategic leadership.

    Your host, Raman Sehgal, discusses the pharma and biopharma ecosystem with Adriana, covering:

    • How her personal story led her into science and biologics, and onto the path of helping build a biopharma hub in Poland
    • How each stage of her career taught her something different, and why CEOs should create the conditions for people to achieve more
    • The importance of purpose, values and doing work that is genuinely meaningful for patients
    • The journey from legacy biosimilars to bringing the first Polish manufactured biologic to the global market, and ultimately into the CDMO world
    • The mindset and culture shift required when moving from an established biologics organisation to a genuinely client centric CDMO business
    • How Rezon Bio is positioning itself for the future around pricing, added value, partnerships and the growing importance of dual sourcing

    Connect with her on LinkedIn.

    Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

    Show More Show Less
    49 mins
  • Why caring is winning in the CRO space
    Nov 6 2026

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development and commercialisation lifecycle with Kevin Jones, CEO of Aliri Bioanalysis.

    Your host, Raman Sehgal, discusses the pharma and biopharma ecosystem with Kevin, covering:

    • His journey from working nights in the lab to leading global commercial and scientific teams
    • Why flexibility, care and a consultative approach are critical differentiators for smaller specialist CROs competing against one stop shop providers
    • What attracted him to Aliri Bioanalysis, and the appeal of joining a fast growing, private equity backed business, something he had not previously experienced
    • How the role and perception of CROs has evolved over the last 30 years, including Kevin’s five principles for what clients value when selecting partners today
    • How the market has begun to rebound after a difficult few years, and why he believes the industry is entering a new molecule renaissance

    Kevin Jones is CEO of Aliri Bioanalysis, a contract research organisation supporting drug developers with regulated bioanalysis and PK/TK testing. He began his career running laboratories and has spent three decades leading large, multidisciplinary scientific teams across both GMP and GLP/clinical environments.

    Kevin previously led Global Bioanalysis at Covance, now Labcorp, and served as Vice President and General Manager of Bioanalytical/ADME, Vaccine and Discovery Laboratories at Q² Solutions, part of IQVIA. His experience spans laboratory operations, global integration and strategic growth, with a particular focus on building service organisations that scale without compromising quality or the client experience.

    Connect with him on LinkedIn.

    Molecule to Market is also sponsored by Bora Pharmaceuticals and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

    Show More Show Less
    52 mins
  • Takeaways from CDMO Live Americas
    Oct 30 2026

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:

    • Ben Locwin, Senior VP at Reliant Life Sciences
    • Jennifer Chadwick, Founder at Jennifer Chadwick Consulting LLC
    • Jeff Buguliskis, Deputy Chief Editor at Outsourced Pharma

    Your host, Raman Sehgal, discusses the takeaways from CDMO with his guests on a live panel from Boston. The event was hosted by PharmaSource and Molecule to Market.

    Molecule to Market is also sponsored by Bora Pharmaceuticals and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

    Show More Show Less
    51 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet